Global Tertiary Amines Market

The fatty amines are used as surfactants in various industries. Fatty amines are characterized as any variation of amine that is associated with at least eight carbon atoms in a hydrocarbon chain. These amines are regularly placed in oleochemicals and are fabricated by the process of hydrogenation in greasy nitriles. These are obtained by hydrogenation of fatty nitriles, which are produced by the reaction between triglycerides, fatty acids, or fatty esters and ammonia with the elimination of two molecules of water at high temperature in the presence of dehydrating catalyst (such as silica gel, alumina, or iron-based catalysts). The main types of product types of fatty amines are primary fatty amines, secondary fatty amines, and tertiary fatty amines. Primary fatty amines are used as cationic surfactants (textile softeners, dyeing aids, anti-static agents, pigment aids, bactericides, and germicides), corrosion inhibitors, amphoteric surfactants (shampoos and detergents), asphalt emulsifiers, anticaking agents for fertilizers, releasing agents for molded rubber parts, fuel additives, and sludge inhibitors. Different functions performed by fatty amines are emulsifiers, floatation agents, anti-caking agents, dispersants, corrosion inhibitors, and chemical intermediates. These fatty amines are used in agrochemicals, oilfield chemicals, asphalt additives, water treatment, chemical synthesis, personal care, and household. The fatty amines market research report is one of a series of new reports from The Business Research Company that provides fatty amines market statistics, including fatty amines industry global market size, regional shares, competitors with a fatty amines market share, detailed fatty amines market segments, market trends and opportunities, and any further data you may need to thrive in the fatty amines industry. This fatty amines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global fatty amines market size grew from $3.74 billion in 2022 to $4.1 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The fatty amines market size is expected to grow to $5.54 billion in 2027 at a CAGR of 7.8%. The increasing demand for liquid detergent will propel the growth of the fatty amines market during the forecast period. Demand for liquid detergent is increasing because of the use of washing machines and dishwashers in urban areas, improvement in living standards, and changes in consumer lifestyle. Consumers are adopting liquid detergent because of its ability to help release and break down stains in fabrics. For instance, a study conducted by Samsung Electronics UK Ltd., a UK electronics company, in November 2020, among the 2,000 UK adults, revealed that approximately two-thirds of Brits (66%) use a liquid detergent to wash their clothes in the washing machine. Thus, the rising demand for liquid detergent will boost the market growth. The development of novel applications and technological innovation are shaping the fatty amines market. Technological innovation and the development of novel applications are important factors that help in raising demand from the industries such as fabric conditioning, paint & coatings, detergents, and mining. For example, in November 2021, according to a research article published by European Federation for Medicinal Chemistry (EFMC), a Belgium-based non-profit organization that represents European medicinal chemistry societies, researchers have achieved the direct synthesis of multiple medium and long chain primary fatty amines in one pot with analytical yields as high as 97 % by coupling a lipase with a carboxylic acid reductase (CAR) and a transaminase (TA). This method of synthesis represents a method of producing primary fatty amines from renewable triglycerides and oils. Additionally, a preparative reaction on a 75 mL scale for trilaurin was conducted, yielding an isolated yield of 73% to the appropriate amine. In December 2020, Huntsman Corporation, a US-based company that manufactures and markets chemical products announced the acquisition of Gabriel Performance Products, for $250 million, to make strategic initiatives in the Advanced Materials division. This deal is expected to broaden the offering of Huntsman in a specialty portfolio that will further enhance toughening and curing agents and other additives used in a wide range of composite, adhesive, and coatings applications. Gabriel Performance Products is a US-based chemical manufacturing company. Major players in the fatty amines market are Kao Corporation, Nouryon, Solvay, Huntsman Corporation, Global Amines Company Pte. Ltd., Evonik Industries AG, Lonza Group Ltd., Ecogreen Oleochemicals GmbH, Indo Amines Limited, Volant-Chem Corp, Arkema S.A., KLK OLEO, India Glycols Limited and ERCA SPA. The Asia-Pacific was the largest region in the fatty amines market in 2022. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in the fatty amines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the fatty amines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The fatty amines market consists of sales of fatty amines that are used in agrochemicals and personal care products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global fatty amines market is segmented - 1) By Product: Primary Fatty Amines, Secondary Fatty Amines, Tertiary Fatty Amines 2) By Application: Agrochemicals Oilfield Chemicals, Asphalt Additives, Water Treatment, Chemical Synthesis, Personal Care, Household 3) By Function: Emulsifiers, Floatation Agents, Anti-Caking Agents, Dispersants, Corrosion Inhibitors, Chemical Intermediates

The term "biosurfactant" refers to a diverse group of molecules, which consist of a polar head (hydrophilic) and a non-polar tail (hydrophobic). They are produced by various microorganisms, which include Acinetobacter sp., Bacillus sp., Candida antartica, and Pseudomonas aeruginosa. They can be used to replace synthetic surfactants in a variety of industrial processes, including lubrication, wetting, softening, fixing dyes, making emulsions, stabilizing dispersions, foaming, and preventing foaming, as well as in the food, biomedical, and pharmaceutical industries, and organic bioremediation. The main types of biosurfactants are glycolipids, phospholipids, surfactin, lichenysin, polymeric biosurfactants, and other product types. The glycolipid surfactants segment consists of sales of glycolipid biosurfactants by entities (organizations, sole traders, and partnerships) that refer to biosurfactants with a structural composition of hydrophilic moieties due to the presence of glucose, mannose, galactose, trehalose, rhamnose, sophorose, and hydrophobic moieties due to the presence of long fatty acid chains. These biosurfactants are synthesized from hydrocarbons, industrial wastes, and frying and olive oil wastes. The biosurfactants are used in detergents, food processing, personal care, agricultural chemicals, and other applications. The biosurfactants market research report is one of a series of new reports from The Business Research Company that provides biosurfactant market statistics, including biosurfactant industry global market size, regional shares, competitors with a biosurfactant market share, detailed biosurfactant market segments, market trends and opportunities, and any further data you may need to thrive in the biosurfactant industry. This biosurfactant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biosurfactants market size grew from $4.07 billion in 2022 to $4.39 billion in 2023, at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biosurfactants market size is expected to grow to $6 billion in 2027 at a CAGR of 8.1%. The increase in demand for personal care industries across the globe is likely to contribute to the growth of the biosurfactant market in the cosmetic and personal care industries. Biosurfactants are used in the manufacturing of personal care products due to their high biodegradability, low toxicity, multi-functionality, environmental capability, and other factors. Moreover, biosurfactants can be used as wetting agents, solubilizers, dispersants, foaming agents, cleaners, detergents, and emulsion-forming agents. According to the study published by Nielsen Holdings, a USA-based data and market measurement firm, the sales of health, personal care, and beauty products are expected to increase from $53.12 billion in 2019 to $99.12 billion in 2023. Thus, the rapid growth in the personal care sector is expected to boost demand for biosurfactants during the forecast period. Technological development is a key trend gaining popularity in the biosurfactant market. The companies operating in the biosurfactant sector are investing in the development of new biosurfactants to meet the technical demands of different end-use industries across the globe. For instance, in March 2022, Evonik Industries, a Germany-based manufacturer of specialty chemicals, launched Rewoferm RL 100 Biosurfactant to meet the growing demand for low-emission and low-impact cleaning products. Rewoferm RL 100 Biosurfactant is manufactured from locally sourced feedstocks and offers effective cleaning performance. In December 2020, Stepan Company, a USA-based manufacturer of specialty chemicals, acquired Logos Technologies LLC’s NatSurFact business for an undisclosed amount. Through this acquisition, Stepan is planning to build on NatSurFact's work in the next few years to commercialize innovative surfactants and follow their commitment to building sustainable products. NatSurFact is a biosurfactant line based on rhamnolipids. Logos Technologies, LLC, is a technology firm dedicated to providing customers with dependable and innovative solutions. Major players in the biosurfactants market are AGAE Technologies, Croda International plc, Evonik, GlycoSurf, Jeneil, Kemin Industries Inc., Lion Corporation, TensioGreen, Biotensidon, Holiferm, Rhamnolipid, Saraya, Stepan Company, Victex, and Dispersa. Western Europe was the largest region in the biosurfactants market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosurfactants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biosurfactants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biosurfactant market consists of sales of lipopeptides and fatty acids for use as biosurfactants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biosurfactants market is segmented - 1) By Product Type: Glycolipids, Phospholipids, Surfactin, Lichenysin, Polymeric Bio-Surfactants, and Other Product Types 2) By Application: Detergents, Personal Care, Food Processing, Agricultural Chemicals, Other Applications

The antifungal drugs refer to drugs that are used to detect and eliminate fungal pathogens. The fungal pathogens thrive in the body in unhygienic and unclean environments. These drugs are also known as antimycotic medications, used to treat and prevent mycoses such as athlete's foot, ringworm, candidiasis (thrush), and serious systemic infections such as cryptococcal meningitis, and others. The main types of drugs in antifungals are echinocandins, azoles, polyenes, and allylamines. Echinocandins are a new type of antifungal medication that works by inhibiting the formation of 1,3-D-glucan, a key component of the fungal cell wall, in an entirely fungal-specific manner. The different routes of administration include oral, parenteral, and topical and involve various therapeutic indications such as aspergillosis, dermatophytosis, candidiasis, and others. The several sectors include hospitals and clinics, dermatology clinics, and other users. The antifungals market research report is one of a series of new reports from The Business Research Company that provides antifungals market statistics, including antifungals industry global market size, regional shares, competitors with antifungals market share, detailed antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the antifungals industry. This antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global antifungals market size will grow from $31.12 billion in 2022 to $35.19 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antifungals market size is expected to grow to $54.88 billion in 2027 at a CAGR of 11.8%. A point prevalence survey was conducted in Turkey. According to the survey, antifungal drugs were mostly prescribed in pediatrichematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%). The other units prescribing antifungal drugs included pediatric services (18.3%), pediatric ICUs (PICUs) (14.6%), and hematopoietic (HSCT) units (7.3%). According to the same survey, the antifungals were used for prophylaxis in 48.8% of patients and about 50% of patients were treated with antifungal drugs based on observation. Among 50% of patients, who were treated post-observation, around 18.8% of patients have prescribed an antifungal therapy, and 31.2% of patients were targeted for the treatments. The increasing prevalence of fungal infections is expected to propel the growth of the antifungals market. Diseases such as SARS, Zika virus, Ebola and COVID-19 have increasingly led to infections in various parts of the world, leading to an increase in the global disease burden. According to the World Health Organization (WHO), in 2022, over the course of the COVID-19 pandemic, the number of fungal infections increased markedly amongst hospitalized patients. In addition, according to a 2022 article published in British weekly scientific journal, Nature, there was a spike in invasive Candida infections in patients with COVID-19 in the intensive care units (ICUs) of Wuhan, China. Additionally, during the second wave of the pandemic, India reported more than 47,500 cases of COVID-19 associated mucormycosis between May and August 2021. Hence, the increasing incidence of fungal infections is expected to drive the market in the forecast period. Antifungal drug manufacturers are offering skimming prices for branded drugs. The discovery, development, and manufacturing processes of branded drugs generally require high investments. As a result, companies in the market offer branded drugs at the highest initial prices and implement other pricing strategies to ensure the product stays competitive at a high price. Price skimming is a pricing strategy in which a company charges a high initial price and then gradually lowers the price to attract more price-sensitive customers. It is used to maximize profits when a new product is introduced in the market. Manufacturers and marketers of branded drugs should consider adopting the price skimming strategy for branded drugs. They should price these branded drugs high to recover the high costs incurred during drug development and manufacturing. Drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand their product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase revenues and stay competitive in the market. Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories, Sanofi-Aventis, Kramer Laboratories, GlaxoSmithKline Gilead, Enzon Pharmaceuticals Inc., and Basilea Pharmaceuticals AG. North America was the largest region in the drugs for antifungals market in 2022. The Middle East is expected to be the fastest-growing region in the global antifungals market. The regions covered in the global antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The antifungal market consists of sales of clotrimazole, miconazole, and ketoconazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global antifungals market is segmented - 1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines 2) End users: Hospitals & Clinics, Dermatology clinics, Other Users 3) By Route of Administration: Oral, Parenteral, Topical 4) By Therapeutic Indications: Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications

The antiemetics and antinauseants refer to drugs that are used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. Antiemetic and antinauseant drugs prevent, control, or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu, or chemotherapy. These drugs reduced the symptoms of nausea or vomiting by blocking signal messages to the part of the brain that controls nausea and vomiting. The main types of drugs in antiemetics and antinauseants are dopamine antagonists, nk1 receptor antagonists, antihistamines (h1 histamine receptor antagonists), cannabinoids, and benzodiazepines, anticholinergics, steroids, 5-ht3 receptor antagonists, and others. A dopamine antagonist also referred to as an anti-dopaminergic or a dopamine receptor antagonist, is a medication that works by blocking dopamine receptors. It is used in chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, and others and is implemented in various sectors such as hospitals, medical centers, clinics, and research institutes. The antiemetics and antinauseants market research report are one of a series of new reports from The Business Research Company that provides antiemetics and antinauseants market statistics, including antiemetics and antinauseants industry global market size, regional shares, competitors with antiemetics and antinauseants market share, detailed antiemetics and antinauseants market segments, market trends and opportunities, and any further data you may need to thrive in the antiemetics and antinauseants industry. This antiemetics and antinauseants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global antiemetics and antinauseants market size will grow from $7.76 billion in 2022 to $8.09 billion in 2023 at a compound annual growth rate (CAGR) of 4.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antiemetics and antinauseants market size is expected to grow to $9.12 billion in 2027 at a CAGR of 3.0%. The antiemetics and antinauseants market is driven by the increase in the prevalence rate of cancer. Chemotherapy is one of the most recommended treatments to cure cancer, and chemotherapy-induced nausea and vomiting (CINV) are some of the side effects of the treatment. Antiemetics can help prevent CINV in about 60%-70% of patients. According to the WHO reports, the incidence of cancer globally has risen to 18.1 million new cases and 9.6 million deaths. According to another report by the Centers for Disease Control and Prevention, about 650,000 cancer patients in the USA receive chemotherapy in an outpatient oncology clinic each year. The CINV caused by chemotherapy treatments is cured by using antiemetic and antinauseant drugs like Dolasetron (Anzemet), Ranitidine (Zantac), and other serotonin 5-HT3 receptor types of antagonists. An increase in the incidence of cancer will increase demand for antiemetics and antinauseants, thereby driving revenue for the market. Lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners restrains the market. Despite the presence of a range of drugs, the practitioners prescribe similar drugs to treat patients with different conditions of nausea. The popularity of only a few drugs leads to lower demand for other drugs and thus restricts the overall growth of this market. For example, the American Society of Clinical Oncology released its first guideline in the ‘Choosing Wisely’ (CW) campaign to prevent and discourage the overuse of expensive and similar kinds of antiemetic drugs for all ailments. Manufacturers are exploiting nanotechnology in the antiemetics and antinauseants market to deliver therapeutic agents to specifically targeted sites in a controlled manner through Nanomedicine and Nano delivery systems. Nanomedicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures, and systems by controlled manipulation of size and shape at the nanometer scale. The antiemetic and antinauseant drug manufacturers are inclining more toward the use of Nanomedicine or Nano drugs to make the drug effective and increase their revenues. For instance, Merck & Co., an American multinational pharmaceutical company manufactured Aprepitant under the brand name Emend. It is the first FDA-approved drug for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) that uses nanotechnology to increase the absorption of the drug more easily and efficiently. The antiemetics and antinauseants market is regulated by government agencies such as US Food and Drug Administration. In the USA, title 21 of the Food and Drug Administration Department of Health and Human Services, U.S. part 336, contains conditions that all Antiemetic and Antinauseant drugs are required to fulfil to remain in the market, such as definitions, regulations, and regulations related to the labelling of the antiemetic drug products. Major players in the antiemetics and antinauseants market are Johnson & Johnson, Sanofi-Aventis, Pfizer, GlaxoSmithKline, Abbott Laboratories, Eli Lilly and Company, Merck, Eisai, Bristol-Myers Squibb, and SRS Pharmaceuticals. North America was the largest region in the drugs for antiemetics and antinauseants market in 2022. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market. The regions covered in the global antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antiemetics and antinauseants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The antimetics and antinauseants market consists of sales of dopamine, serotonin, neurokinin, histamine, and acetylcholine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global antiemetics and antinauseants market is segmented - 1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types 2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types 3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

The emulsifiers act as a surfactant that stabilizes the emulsions. Emulsifiers also called emulgent, are surface-active agents that act at the interface between two immiscible liquids such as oil and water, allowing them to be blended into stable emulsions, by maintaining the stability of the mixture. Emulsifiers also reduce stickiness, control crystallization, and prevent separation and are present in ready-made sauces, mayonnaise, soups, and many other food products in which the combination of oil and aqueous phase is needed. They are also found in dairy products such as milk, cream, butter, cheese, yogurt, and various kinds of sweets, such as chocolate, chocolate bars, marshmallows. The main types of products in emulsifiers are lecithin, mono and di-glycerides, stearyl lactylates, sorbitan esters, polyglycerol esters, and others. The lecithin is used in food applications as a viscosity modifier, lubricant, dispersant, and aerating agent. The lecithin emulsifier's molecular structure makes it a good emulsifier for water-oil interaction. The different chemical structures include natural, synthetics, semi-synthetics, and are used in food emulsifiers, cosmetics and personal care, oilfield chemicals, pharmaceutical, agrochemicals, others. The emulsifiers market research report is one of a series of new reports from The Business Research Company that provides emulsifiers market statistics, including emulsifiers industry global market size, regional shares, competitors with a emulsifiers market share, detailed emulsifiers market segments, market trends and opportunities, and any further data you may need to thrive in the emulsifiers industry. This emulsifiers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global emulsifiers market size grew from $5.92 billion in 2022 to $6.34 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The emulsifiers market size is expected to grow to $8.35 billion in 2027 at a CAGR of 7.1%. The increasing demand for emulsifiers in the food industry for packaged and convenience food worldwide is contributing to the growth of the emulsifiers market. Food emulsifiers are increasingly being used in packaged and convenience food products to prevent microbial spoilage. Demand for packaged and ready-to-eat food is growing over time due to busy lifestyles, changing eating habits of the population, and the spread of COVID-19 pandemic. For instance, according to Credit Suisse, a Switzerland-based investment banking company, retail sales of packaged food firms in the USA increased from 15% to 30% on average from March to May 2020. Hence, the increasing demand for emulsifiers in the food industry is expected to drive the growth of the emulsifiers market. The increasing investment in research and development to make natural emulsifiers are shaping the emulsifiers market. Major companies operating in the emulsifiers sector are focused on developing and launching natural emulsifiers for use in manufacturing organic hair care and skincare formulations and food products. For instance, in March 2020, Ingredion, a US-based ingredient provider launched a broth emulsifier called Evanesse made from chickpeas. The product is considered as a replacement for eggs or uses in dressings and sauces, without and affecting taste or texture. Evanesce can replace OSA modified starches and other artificial emulsifiers and help food manufacturers looking to tout front-of-package claims on their products, such as natural or no artificial ingredients. In August 2021, Infineum, a UK-based specialty chemical company signed a contract to acquire the ISCA UK emulsifiers business unit for an undisclosed amount. The agreement secures ISCA UK's formulation expertise and the ISCAMUL emulsifier brand. This acquisition represents Infineum's return to the emulsion explosives industry, where its current capabilities can be utilized to better serve current and potential new customers. ISCA UK is a UK-based manufacturer of specialty chemicals. Major players in the emulsifiers market are BASF SE, The Dow Chemical Company, Kerry Group, Clariant, Evonik Industries, Cargill, Archer Daniels Midland, Stepan Company, Solvay S.A, Palsgaard A/S, Puratos Group., Spartan Chemical Company, The Lubrizol Corporation, Royal DSM N.V., and Beldem S.A. Asia-Pacific was the largest region in the emulsifiers market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emulsifiers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the emulsifiers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The emulsifiers market consists of sales of emulsifying agents including polymers and sodium lauryl sulfate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global emulsifiers market is segmented - 1) By Product: Lecithin, Mono and Di-Glycerides, Stearyl Lactylates, Sorbitan Esters, Polyglycerol Esters, Other Products 2) By Chemical Structure: Natural, Synthetic, Semi-Synthetic 3) By Application: Food Emulsifiers, Cosmetics And Personal Care, Oilfield Chemicals, Pharmaceutical, Agrochemicals, Other Applications

Dermatitis refer to the inhibitors that treat skin inflammation, which is characterised by itchy rashes on swollen and reddish skin, in the outer layer of the body. It is a general term that describes a common skin irritation. The main classes of drugs in dermatitis are corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, and interleukin inhibitors. Corticosteroids are a group of steroid hormones generated by vertebrates' adrenal cortex and are also synthetic equivalents of these hormones. The different routes of administration include topical, oral, and injectable and are used in cancer, blood disorders, chronic diseases, and infectious diseases. It is distributed through various channels such as hospitals, retail pharmacies, drug stores, and online or mail pharmacies. The dermatitis market research report is one of a series of new reports from The Business Research Company that provides dermatitis market statistics, including dermatitis industry global market size, regional shares, competitors with a dermatitis market share, detailed dermatitis market segments, market trends, and opportunities, and any further data you may need to thrive in the dermatitis industry. This dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global dermatitis market size will grow from $6.46 billion in 2022 to $6.89 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global dermatitis market size is expected to grow to $8.57 billion in 2027 at a CAGR of 5.6%. Growth in the atopic dermatitis market is primarily driven by the increasing global prevalence of the disease. The prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for the medicines to cure this disease. For example, according to the allergy asthma network 2020, approximately 31.6 million people in the United States have some form of atopic dermatitis. The prevalence of atopic dermatitis globally in children have 15-20 percent and in adults have 1 to 3 percent. The strict government regulations are one of the restraints for the dermatitis drug market. Atopic Dermatitis (eczema) usually occurs at a very early stage (0-5 years). To find the efficacy and efficiency of the drug, it has to be tried on every type of patient. The effects of certain drugs in adults are quite different than in children, as a reasonable result of the clinical trial cannot be used for the production of drugs that will be served to the children. This hinders the research and requires more effort in clearing regulations set by FDA. For example, as the patient population is largely children, the FDA in its CFR Code Title 21, Part 50 Protection of Human Subjects, and subpart D has laid down guidelines for the additional safeguard for children in clinical investigation. The regulation complies with the Children’s Health Act of 2000 which requires all children subjected to clinical trials to be given additional protection. The dermatitis market has witnessed a trend of increasing mergers and acquisitions (M&As), done with the purpose of business expansion and increasing visibility. M&As are playing a significant role in today's world and are assumed to expand this market in the years to come. The vendors in this industry are focusing on collaboration and partnerships to expand their portfolios and improve their market presence. Companies are also strategically making M&As to reduce competition and increase the scalability of their businesses. For instance, in January 2020, Eli Lilly and Company, a US-based pharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of human drugs, acquired Dermira, Inc. for an amount of $1.1 billion. Through this acquisition, Lebrikizumab, an innovative, experimental monoclonal antibody, has been added to the immunology pipeline and marketed dermatology medicines in the product portfolio of Eli Lilly for the treatment of moderate-to-severe atopic dermatitis in patients 12 years of age and older. Dermira, Inc. is a US-based biopharmaceutical company pioneering in the discovery and development of novel therapies for dermatology patients. The dermatitis drugs market is governed by several regulatory bodies that require the drug manufacturers to get approvals from the concerned authorities before launching their medicines into the market. Two such major regulatory bodies are PMDA (Japan) and CDSCO (India) which carry out quality checks before declaring the drugs suitable for consumption. PMDA reviews the products to ensure the safety, quality, and efficacy of pharmaceuticals and then approves the products that are suitable in every parameter. Similarly, CDSCO is the central drug authority that is responsible for the approval of new drugs in India. These tedious approval processes make the drugs more effective and safe, thereby having a positive impact on the dermatitis drugs market. Major players in the dermatitis market are LEO Pharma A/S, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan PLC. (Republic of Ireland) and Bristol-Myers Squibb. North America was the largest region in the dermatitis market in 2022. Middle East is expected to be the fastest-growing region in the global dermatitis market during the forecast period. The regions covered in the global dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The dermatitis market consists of sales of Stasis dermatitis, atopic dermatitis, and irritant contact dermatitis. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global dermatitis market is segmented - 1) By Drug Class: Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors 2) By Distribution Channel: Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies 3) By Route Of Application: Topical, Oral, Injectable 4) By Application: Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases

Oleochemicals refers to chemical compounds sourced from vegetables, plants, and animal oils that can be used as raw material in a variety of industries such as lubricants, pharmaceutical, plastic, rubber, and animal feed industries. Hydrolysis is the primary method for converting animal and plant oils and fats into oleochemicals. When natural triglycerides are exposed to water, heat, and pressure, they separate into crude glycerin and mixed fatty acids. The main types of oleochemicals include specialty esters, fatty acid methyl esters, glycerol esters, alkoxylates, and fatty amines. The fatty acid methyl refers to fatty acid esters derived from the transesterification of fats with methanol. They are used to manufacture detergents and biodiesel. They are sold through direct and indirect sales channels. They are used in the manufacturing of various products ranging from personal care & cosmetics, consumer goods, food processing, textiles, paints & inks, industrial, healthcare & pharmaceuticals, and polymers and plastic additives. The oleochemicals market research report is one of a series of new reports from The Business Research Company that provides oleochemicals market statistics, including oleochemicals industry global market size, regional shares, competitors with an oleochemicals market share, detailed oleochemicals market segments, market trends and opportunities, and any further data you may need to thrive in the oleochemicals industry. This oleochemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global oleochemicals market size grew from $24.78 billion in 2022 to $26.91 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The oleochemicals market size is expected to grow to $37.61 billion in 2027 at a CAGR of 8.7%. The increased demand for sustainable plastics is expected to propel the oleochemical market. The use of plastic and other non-biodegradable materials has caused several environmental issues forcing industries and customers to adapt to sustainable plastics. The use of sustainable plastic is intended to reduce inefficiencies that contribute to environmental harm and aid in the optimization of business operations. This surge in consumer demand for environmentally friendly plastic opens up new markets, particularly in the cosmetics, pharmaceutical, fashion, and food industries for oleochemicals. For instance, In December 2020, European Bioplastics, an association representing the interests bioplastics industry in Europe, stated that global bioplastics production capacity is expected to rise from approximately 2.1 million tons in 2020 to 2.8 million tons in 2025 in Europe. Therefore, the increased demand for sustainable plastics is expected to boost the oleochemicals market during the forecast period. Technological innovation is a key trend gaining popularity in the oleochemicals market. Major companies operating in the oleochemical market are focused on providing technologically-innovative solutions to meet end-customer demands and strengthen their market position. These companies are innovating next-generation chemical solutions technologies into their solution, such as bio-diluent, cosmetic emollient, dispersant, blowing agent management, rigid foam formulators, and others, to provide an alternative to replace fossil fuels. For instance, In September 2020, Emery Oleochemicals, a natural-based specialty chemicals manufacturer, announced EMERY® E fatty acid esters product line. These fatty acid esters offer better color stability and low odor and are biodegradable. In November 2021, Mega First Corporation Berhad, a Malaysia-based engaged in asset management and investment holding acquired EMERY OLEOCHEMICALS (M) SDN BHD and EMERY SPECIALTY CHEMICALS SDN BHD for $8.27 million. The acquisition is expected to assist Mega First Corp. with its in-house talent recruitment goal, as well as its plantation division's core technical capabilities when it expands into coconut and other agricultural produce processing in two to three years. Emery Oleochemicals (M) Sdn. Bhd is a Malaysia-based high-performance, natural-based specialty chemicals manufacturer. Major players in the oleochemicals market are Cargill Inc., Kuala Lumpur Kepong Berhad, BASF SE, Oleon N.V., IOI Group Berhad, Wilmar International, Kao Corp, Emery Oleochemicals Group, Evonik Industries, KLK Oleo, SABIC, Evyap Oleo, Procter & Gamble Company, Croda Industrial Chemicals, and Ecogreen Oleochemicals. Asia-Pacific was the largest region in the oleochemicals market in 2022, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the oleochemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oleochemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The oleochemicals market consists of sales of alkoxylates and palm oil. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global oleochemicals market is segmented - 1) By Product: Specialty Esters, Fatty Acid Methyl Ester, Glycerol Esters, Alkoxylates, Fatty Amines 2) By Application: Personal Care & Cosmetics, Consumer Goods, Food Processing, Textiles, Industrial, Healthcare & Pharmaceuticals 3) By Sales Channel: Direct, Indirect

Chemical compounds are substances that are produced based on the transformation of organic and inorganic raw materials by a chemical process and the formulation of products. Chemicals have characteristics such as flammability, toxicity, acidity, reactivity, and heat of combustion. The main types of chemicals are general chemical products, printing inks, toiletries, soap and cleaning compounds, adhesives, paints and coatings, pesticide and other types of agricultural chemicals, chemical fertilizers, synthetic rubber and fibers, plastic material and resins, ethyl alcohol, and other basic types of organic chemical, and other types of basic inorganic chemical, synthetic dye, and pigment, industrial gas, and petrochemicals. Printing ink is ink used in printing and contains a pigment or pigments of the required color mixed with oil or varnish. The types of intermediate chemicals are methanol, ethylene oxide, and propylene oxide. The end-users involved are pharmaceuticals, agrochemicals, water treatment, construction, paints and dyes, oil and gas, rubber chemicals, surfactants, personal care, and other end-users. The chemicals market research report is one of a series of new reports from The Business Research Company that provides chemicals market statistics, including chemicals industry global market size, regional shares, competitors with a chemicals market share, detailed chemicals market segments, market trends and opportunities, and any further data you may need to thrive in the chemicals industry. This chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global chemicals market grew from $4700.13 billion in 2022 to $5079.29 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chemicals market is expected to grow to $6851.59 billion in 2027 at a CAGR of 7.8%. Interest rates were low in most developed countries during this period. This positively impacted the growth of the chemicals market. For instance, in March 2020, the Bank of England, a UK-based central bank, reduced interest rates to 0.1%, the lowest level ever, as a measure of protest against COVID-19. These low-interest rates encouraged borrowing and increased the flow of money for investment. This allowed chemical companies to borrow money for process improvements, thus driving the market during the historic period. Rising costs had a negative impact on the growth of the industrial gas market during the forecast period. This rise in raw material costs resulted in higher manufacturing costs, thus decreasing the investments available for research and development of new products. Additionally, companies invested heavily in marketing their products due to intense competition in the market. Rising trucking, railroad, dry-bulk, and air-freight rates also negatively impacted the market. This rise in operating costs increased the pressure on companies to protect margins while maintaining the quality of their products. Chemical companies are increasingly adopting sustainable and eco-friendly processes to eliminate the negative impact of chemical manufacturing on the environment. Evolution in technology and chemical sciences enables chemical companies to utilize alternative fuels to produce chemical products. They are using naturally available carbon dioxide to produce fuels, industrial products, and other substances. For instance, Akzo Nobel N.V., a chemicals and coatings giant, is planning to make a seven-figure investment in Green Lizard Technologies’ patented process to make surfactants from plants rather than from oils. Major companies in the chemicals market include JXTG Holdings Inc., Sinopec Limited, BASF SE, Procter & Gamble, Unilever plc, L'Oreal SA, Dow Inc., Saudi Basic Industries Corporation (SABIC), Mitsubishi Chemical Holdings Corp, and Guardian Industries, LLC. Asia-Pacific was the largest region in the chemicals market in 2022. North America was the second-largest region in the chemicals market. The regions covered in the chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the chemicals market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The chemicals market consists of the sales of petrochemicals, industrial gas, ethyl alcohol, organic chemicals and inorganic chemicals, resins, synthetic rubber, and artificial and synthetic fibers and filaments, pesticides, fertilizers, and other agricultural chemicals. The chemicals industry establishments produce a variety of chemical products by processing raw materials such as air, water, natural gas, oil, metals and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global chemicals market is segmented - 1) By Type: General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals 2) By Type of Intermediate Chemicals: Methanol, Ethylene Oxide, Propylene Oxide 3) By End User: Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users Subsegments Covered: Oil-Based Printing Inks, Solvent-Based Printing Inks, Water-Based Printing Inks, Lotions (Including Sunscreens), Hair Preparations, Face Creams, Perfumes, Shaving Preparations, Other Cosmetic Preparations, Soap and Other Detergents, Surface Active Agents, Polish and Other Sanitation Goods, Water-Based Adhesives, Solvent-Based Adhesives, Hot-Melt-Based Adhesives, Reactive & Other Adhesives, Water Borne Coatings, Solvent Based Coatings, Powder Coatings, Other Paints and Coatings, Herbicides, Insecticides, Fungicides, Other Pesticide and Other Agricultural Chemicals, Nitrogen Fertilizer, Phosphate Fertilizer, Potash Fertilizer, Synthetic Fibers, Styrene Butadiene Rubber (SBR), Polybutadiene (BR), Ethylene Propylene (EPDM), Other Synthetic Rubber and Fibers, Polypropylene-Plastic Material and Resins, High-Density Polyethylene, Poly-Vinyl Chloride, Polyethylene Terephthalate, Polyurethane, Low-Density Polyethylene, Polystyrene-Plastic Material and Resins, Other Plastic Material and Resins, Synthetic Sweeteners, Plasticizers, Ethyl Alcohol, Silicone (except Resins), Fatty Acids, Gum and Wood Chemicals Synthetic Dye, Synthetic Pigments, Nitrogen, Oxygen, Carbon Dioxide, Hydrogen, Other Industrial Gas, Ethylene-Petrochemicals, Propylene-Petrochemicals, Benzene-Petrochemicals, Xylene, Styrene-Petrochemicals, Toluene, Cumene, Other Petrochemicals